new-kit-box new-kit-box

No-Wash Assay for hKi-67 Detection​

  • Increase confidence in your data with a robust assay response
  • Decrease prep time using a fast, no-wash, add-and-read protocol​
  • Make quicker decisions by using an earlier readout of proliferation​

Catalog Number:

Size

Catalog Number: GC1000

Preis anfragen

Catalog Number: GC1002

Preis anfragen


Overview
Protocols
Specifications
Resources
Compare Products

Quickly and Easily Assess Cell Proliferation

Cell proliferation is a fundamental parameter of cell-based research that is assessed across numerous application workflows. Investigators currently monitor cell proliferation with methods that are laborious and unreliable, often requiring treatment times of 72–96 hours.

The Lumit® Cell Proliferation Assay (Human Ki-67) is a simple add-and-read plate-based assay that enables researchers to track hKi-67, a well-known marker of cell proliferation, without complicated washing steps. With a robust response detectable at earlier time points, researchers can generate more data with higher confidence along with reduced prep work and time to results.

Watch the video to hear how researcher Clara Gouez is using the Lumit® Cell Proliferation Assay (Human Ki-67) to advance her gastric cancer research.

How the Lumit® Cell Proliferation Assay Works

The Lumit® Cell Proliferation Assay (Human Ki-67) is based on Lumit® Technology. Primary antibodies to hKi-67 were selected for their specific and sensitive detection and labeled with the LgBiT and SmBiT subunits of NanoBiT® Luciferase. In the presence of hKi-67, the subunits are brought together to form an active luciferase enzyme. Addition of optimized substrate generates a bright luminescent signal proportional to hKi-67 levels.

Illustration showing how the Lumit® hKi-67 Immunoassay works.

Simple Protocol Requires No Wash Steps

Illustration of the Lumit® hKi-67 Immunoassay protocol.
Compared with conventional fixation-based Ki-67 flow cytometry, the assay is significantly simpler and faster, requiring no dissociation or wash steps while still producing robust and reproducible results.

Zeynep Kaya, PhD, Postdoctoral Research Fellow, Prof Andrew Beggs Group, University of Birmingham

Broad Linear Range and Specific hKi-67 Detection

The Lumit® Cell Proliferation Assay demonstrates excellent linearity in microplate formats and specifically detects hKi-67 levels.

Line graph showing highly linear luminescence response (r²=0.998) across Jurkat cell titration in a 96-well plate format using the Lumit® Cell Proliferation Assay (Human Ki-67).
Bar graph showing strong luminescence signal in wild-type HeLa cells and near-zero signal in Ki-67 knockout and no-cell controls, demonstrating specific hKi-67 detection using the Lumit® Cell Proliferation Assay (Human Ki-67).
Line graph showing highly linear luminescence response (r²=0.992) across Jurkat cell titration in a 384-well plate format using the Lumit® Cell Proliferation Assay (Human Ki-67).

Measure Decreases in Cell Proliferation

Dose-response curves for palbociclib and BAY-1895344 in Jurkat cells, showing neither compound induces cytotoxicity at tested concentrations using the Lumit® Cell Proliferation Assay (Human Ki-67).
Dose-response curves showing palbociclib (EC₅₀=42nM) and BAY-1895344 (EC₅₀=85nM) reduce Ki-67 expression in a dose-dependent manner using the Lumit® Cell Proliferation Assay (Human Ki-67).
Dose-response curves showing palbociclib (EC₅₀>10µM) and BAY-1895344 (EC₅₀=155nM) effects on Jurkat cell metabolic activity using the Lumit® Cell Proliferation Assay (Human Ki-67).

Treatment of Jurkat cells (10,000/well, 384-well plate, ¼ standard 96-well volumes) with increasing concentrations of compounds. Both compounds reduced hKi-67 expression levels in a dose-dependent manner; however, BAY-1895344 induced cytotoxicity. Palbociclib produced a large change in hKi-67 levels without causing cytotoxicity after only 24 hours of treatment, enabling earlier assessment of compound effects on proliferation. Palbociclib’s effect appears minimal based on total ATP content.


Measure Increases in Cell Proliferation

Bar graph showing treatment of CD8+ T cells with IL-2; a CD3/CD28 T Cell activator reveals only modest T cell proliferation, as measured using the Lumit® Cell Proliferation Assay (Human Ki-67).
Bar graph showing treatment of CD8+ T cells with IL-2; a CD3/CD28 T Cell activator reveals significant upregulation of Ki-67, as measured using the Lumit® Cell Proliferation Assay (Human Ki-67).

Human CD8+ T cells (StemCell Tech) plated at 80,000 cells per well were treated with CD3/CD28 T cell activator with (teal) and without (purple) 10ng/ml IL-2 for 48 hours. Upregulation of hKi-67 is observed with the Lumit® Cell Proliferation Assay before T cell proliferation (which begins >72 hours after activation), demonstrating use of this assay as an early indicator of proliferation.


Compatible with 3D Culture Methods

Dose-response curves for nutlin-3a in HCT116 3D spheroids comparing the Lumit® Cell Proliferation Assay (hKi-67) protein (EC₅₀=1.8µM) and total ATP content (EC₅₀=3.3µM), showing Ki-67 as a more sensitive early indicator of antiproliferative activity.

In 3D spheroids, decreases in hKi-67 protein levels provide a clear and early indication of antiproliferative activity with a larger response window than a metabolic measure of viable cell number. HCT116 cells (1,000 cells/well) were plated in SBio PrimeSurface 96U plates (ULA; round bottom) and grown for 3 days to form 3D spheroids. The resultant HCT116 spheroids were then treated for 24 hours with increasing concentrations of nutlin-3a. Subsequently, proliferation was assessed with the Lumit® Cell Proliferation Assay (Human Ki-67) and a metabolic activity assay in separate plates. Note: Day 4 untreated HCT116 spheroids were ~440µm in diameter.

Specifications

Catalog Number:

Lieferumfang

Produkt Katalognummer Größe

CellTox™ Green Dye, 1,000X

G873A 1 × 20μl

Human Ki-67 Protein (Partial) Positive Control

GC100A 1 × 25μl

Anti-hKi-67 mAb SmBiT, 400X

GC101A 1 × 60μl

Anti-hKi-67 mAb LgBiT, 400X

GC102A 1 × 60μl

Lumit® Immunoassay Buffer C, 10X

VB115C 1 × 1.8ml

Lumit® Lysis Buffer II, 10X

VB310C 1 × 1.3ml

Ki-67 Assay Substrate

VB321A 1 × 600μl

Lumit® Detection Buffer B

VB406D 1 × 6ml

Analysezertifikat

Search by lot number

Nutzungseinschränkung

For Research Use Only. Not for Use in Diagnostic Procedures.

Lagerhinweise

BB

Patente und Haftungsausschlüsse

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

Lieferumfang

Produkt Katalognummer Größe

CellTox™ Green Dye, 1,000X

G873B 1 × 200μl

Human Ki-67 Protein (Partial) Positive Control

GC100A 1 × 25μl

Anti-hKi-67 mAb SmBiT, 400X

GC101A 5 × 60μl

Anti-hKi-67 mAb LgBiT, 400X

GC102A 5 × 60μl

Lumit® Immunoassay Buffer C, 10X

VB115C 5 × 1.8ml

Lumit® Lysis Buffer II, 10X

VB310C 5 × 1.3ml

Ki-67 Assay Substrate

VB321A 5 × 600μl

Lumit® Detection Buffer B

VB406D 5 × 6ml

Analysezertifikat

Search by lot number

Nutzungseinschränkung

For Research Use Only. Not for Use in Diagnostic Procedures.

Lagerhinweise

BB

Patente und Haftungsausschlüsse

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

Compare Products

CellTiter-Glo® 2.0

Cell Viability (ATP)

CellTiter-Glo® (original)

Cell Viability (ATP)

CellTiter-Glo® 3D

3D Cell Viability (ATP)

RealTime-Glo™ MT

Real-Time Viability

CellTiter-Fluor™

Non-Lytic Viability

Lumit® hKi-67

Cell Proliferation

Best Use Routine viability & HTS screening Established protocols using original formulation 3D spheroids, organoids, microtissues Kinetic monitoring over time; downstream multiplexing Multiplex first step; cells needed for follow-up assays True proliferation readout independent of metabolism
Key Decision Points
Measures Viability Viability Viability (3D) Viability (kinetic) Viability Proliferation
Cells alive after assay? ✗ Lytic ✗ Lytic ✗ Lytic ✓ Non-lytic ✓ Non-lytic ✗ Lytic
Multiplexing compatible? LimitedLytic—must be terminal step LimitedLytic—must be terminal step LimitedLytic—must be terminal step ✓ ExcellentNon-lytic; pair with any downstream assay ✓ ExcellentNon-lytic; pair with Caspase-Glo®, CTG, etc. ModerateCan multiplex with CellTox™ Green or other fluorescent readouts
Real-time monitoring? ✗ Endpoint ✗ Endpoint ✗ Endpoint ✓ Up to 72hRead same wells repeatedly ✗ Endpoint ✗ Endpoint
3D culture compatible? PartialWorks for small spheroids; use 3D version for dense structures PartialSame as 2.0 ✓ OptimizedEnhanced lysis for dense 3D structures PartialSubstrate must penetrate; best for small/loose 3D models PartialSubstrate access may be limited in dense 3D ✓ YesDetects Ki-67 in cell lysates from any culture format
Assay Attributes
Assay Principle ATP quantitation (luciferase/luciferin) ATP quantitation (luciferase/luciferin) ATP quantitation (enhanced lysis for 3D) Metabolic reduction of pro-substrate to luciferase substrate Live-cell protease activity (GF-AFC cleavage) Ki-67 immunodetection via NanoBiT® complementation
Detection Mode Luminescence Luminescence Luminescence Luminescence Fluorescence400Ex / 505Em Luminescence
Reagent Format Ready-to-use liquid Buffer + lyophilized substrateRequires reconstitution Ready-to-use liquid 2 components(enzyme + substrate) Single reagent Antibody mix + detection reagent
Time to Result 10min 10min ~30min ContinuousFirst read: 1–2h after addition 30min ~2h
Practical Considerations
Plate Formats 96, 384, 1536 96, 384, 1536 96, 384 96, 384 96, 384 96, 384
HTS Suitability ✓ Excellent1536-well capable; fast protocol ✓ Excellent1536-well capable ✓ Good ModerateRequires kinetic reader scheduling ✓ Good ✓ Good
Sensitivity (96-well) ~15 cells/well ~10 cells/well Spheroid-dependent <100 cells/well ~40 cells/well Cell line-dependent